Oblique Therapeutics

0 followers


Oblique Therapeutics is developing a new type of antibody-based medication for chronic pain and metastatic cancer.

Industries

+2

Headquarters

Stage

Employees

Links

Org chart

Christer Nordstedt

Collapse
Kjell Andersson
Head of Medicinal Chemistry
Marie Scherlund
Chief Program Officer
Mats Lindskog
Chief Business Officer
Cecilia Larsson
Investor Relations Manager
Hans-Peter Ostler
Styrelseledamot